Biogen Speakers

Adam Keeney

Executive Vice President and Head of Corporate Development · Biogen

1 event

Risk managementInvestor relationsBusiness development

Nanxia Zhao

Scientist · Biogen

1 event

microglianeuroinflammationin vivo model

Eric Hajjar

Former Associate Director, Global Medical Research Operations · Biogen

1 event

AIemerging technologiesclinical trials

Pitch Biogen

Biogen

1 event

healthcarebiotech

Diana Gallagher

SVP, Head of Clinical Development for MS, Immunology and Alzheimer's · Biogen

1 event

Neurodegenerative diseaseImmunology

Ben Collins

Lead, Policy Alliances · Biogen

1 event

policy alliancesbiotech

John Pieracci

Biogen

1 event

biotechnology

Jessica Wu

Scientific Director · Biogen

1 event

neurodegenerative diseasedrug development

Danielle Graham

Vice President & Head of Biomarkers · Biogen

1 event

biomarkersneurodegenerative disease

Adam Feire

Head of Business Development and New Ventures · Biogen

1 event

Pharma dealmakingInnovationFuture trends

Jenny Higley

Director, Head of Feasibility CoE · Biogen

1 event

patient burdensite burdenprotocol design

Anthony Coston

Technical Lead, Device Design & Process Development · Biogen

1 event

device design

Carolyn Reever, PhD

Global Head, Neuropsychiatry & Epilepsy Medical Affairs · Biogen

1 event

medical affairsneuropsychiatrylaunch strategy

Ross Jeggo

Head of Neurology Research · Biogen

1 event

disease-modifying therapiesAlzheimer's & Parkinson'sprecision neurology

Lauren Merrill

Director of TMF and R&D Records Management · Biogen

1 event

risk-based managementR&D recordsclinical trials

Suzanne M. Opalka

1 event

Lisa Shafer

1 event

Madeleine Shin

Biogen

1 event

Corporate strategyBiotech narrative